Page last updated: 2024-12-07

1-leucine-4-nitroanilide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Leucine-4-nitroanilide, also known as **L-leucine-4-nitroanilide**, is a synthetic peptide that acts as a substrate for certain enzymes, particularly those involved in **protein degradation**.

Here's why it's important for research:

**1. Assaying Protease Activity:**

* L-leucine-4-nitroanilide is often used as a substrate in **enzyme assays** to measure the activity of **proteases**, especially **chymotrypsin-like serine proteases**.
* When cleaved by the protease, the 4-nitroanilide group is released, which can be easily detected spectrophotometrically, providing a quantitative measure of the protease activity.

**2. Screening for Enzyme Inhibitors:**

* This substrate is also useful for **screening potential inhibitors** of proteases. By measuring the decrease in activity of the protease in the presence of a potential inhibitor, researchers can identify compounds that block the enzyme's function.

**3. Understanding Enzyme Kinetics:**

* Studying the kinetics of the reaction between L-leucine-4-nitroanilide and proteases can provide insights into the **enzyme's mechanism of action**, including its specificity, affinity for the substrate, and catalytic efficiency.

**4. Studying Protein Degradation Pathways:**

* L-leucine-4-nitroanilide is used in research studying various biological processes involving protein degradation, including:
* **Apoptosis (programmed cell death):** Proteases like caspases are involved in apoptosis and can be studied using this substrate.
* **Inflammation:** Some proteases, like elastase, are released during inflammation.
* **Disease processes:** Many diseases involve dysregulation of proteases, and studying these enzymes using this substrate can be crucial in developing new therapies.

**Overall, 1-leucine-4-nitroanilide is a valuable tool for researchers studying proteases and their roles in a variety of biological processes.** Its use in enzyme assays, inhibitor screening, and kinetic studies provides critical information for understanding protein degradation and its implications in health and disease.

1-leucine-4-nitroanilide: substrate for arylamidase; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121895
MeSH IDM0041774

Synonyms (22)

Synonym
LS-14108
l-leucyl-p-nitroanilide
1-leucine-4-nitroanilide
axzjhdnqdsvidr-uhfffaoysa-
inchi=1/c12h17n3o3/c1-8(2)7-11(13)12(16)14-9-3-5-10(6-4-9)15(17)18/h3-6,8,11h,7,13h2,1-2h3,(h,14,16)
6664-98-8
2-amino-4-methyl-n-(4-nitrophenyl)pentanamide
AKOS003273846
16010-99-4
1-leucyl-4-nitroanilide
1-leucyl-p-nitroanilide
pentanamide, 2-amino-4-methyl-n-(4-nitrophenyl)-
FT-0627937
AKOS017258609
n-1-(4-nitrophenyl)leucinamide
l-leucine-p-nitroanilide(leu-pna)
AT-057/40186971
n1-(4-nitrophenyl)leucinamide
mfcd00036164
FT-0773574
2-amino-4-methyl-4' -nitrovaleranilide
DTXSID501253697
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (45.16)18.7374
1990's8 (25.81)18.2507
2000's6 (19.35)29.6817
2010's3 (9.68)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.69 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]